BG105795A - Derivatives of monosaccharides as cell adhesion inhibitors - Google Patents

Derivatives of monosaccharides as cell adhesion inhibitors

Info

Publication number
BG105795A
BG105795A BG105795A BG10579501A BG105795A BG 105795 A BG105795 A BG 105795A BG 105795 A BG105795 A BG 105795A BG 10579501 A BG10579501 A BG 10579501A BG 105795 A BG105795 A BG 105795A
Authority
BG
Bulgaria
Prior art keywords
cell adhesion
derivatives
monosaccharides
adhesion inhibitors
methods
Prior art date
Application number
BG105795A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sudershan Arora
Madan TANWAR
Jang Gupta
Geeta Sharma
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of BG105795A publication Critical patent/BG105795A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG105795A 1999-01-12 2001-08-08 Derivatives of monosaccharides as cell adhesion inhibitors BG105795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22915599A 1999-01-12 1999-01-12
US09/411,357 US6329344B1 (en) 1998-10-22 1999-10-01 Derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000021 WO2000042053A1 (en) 1999-01-12 2000-01-10 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
BG105795A true BG105795A (en) 2002-05-31

Family

ID=26922990

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105795A BG105795A (en) 1999-01-12 2001-08-08 Derivatives of monosaccharides as cell adhesion inhibitors

Country Status (29)

Country Link
US (1) US6329344B1 (pt)
EP (1) EP1144425B1 (pt)
JP (1) JP2002534529A (pt)
CN (1) CN1254478C (pt)
AR (1) AR033939A1 (pt)
AT (1) ATE269349T1 (pt)
AU (1) AU767948B2 (pt)
BG (1) BG105795A (pt)
BR (1) BR0007489A (pt)
CA (1) CA2359980A1 (pt)
CO (1) CO5170511A1 (pt)
CZ (1) CZ20012541A3 (pt)
DE (1) DE60011568T2 (pt)
DK (1) DK1144425T3 (pt)
ES (1) ES2223447T3 (pt)
HK (1) HK1041006B (pt)
HR (1) HRP20010527B1 (pt)
HU (1) HUP0200097A3 (pt)
ID (1) ID30259A (pt)
IL (2) IL144274A0 (pt)
MA (1) MA25679A1 (pt)
MY (1) MY122723A (pt)
NZ (2) NZ527482A (pt)
PA (1) PA8489601A1 (pt)
PT (1) PT1144425E (pt)
SK (1) SK284568B6 (pt)
TR (1) TR200102031T2 (pt)
WO (1) WO2000042053A1 (pt)
YU (1) YU50101A (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152397A (en) * 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
AU2003202767A1 (en) * 2003-02-12 2004-09-06 Ranbaxy Laboratories Limited Preparation of monosaccharide derivatives
AU2003222399A1 (en) * 2003-05-06 2004-11-26 Ranbaxy Laboratories Limited Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides
JP4901474B2 (ja) 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors
WO2005092908A1 (en) * 2004-03-18 2005-10-06 Ranbaxy Laboratories Limited Base addition salts of monosaccharides derivatives as inhibitors of airway hyper reactivity and airway inflammation
WO2005092907A2 (en) * 2004-03-26 2005-10-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
WO2005100373A2 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
EP1789428A1 (en) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharide derivatives
WO2007063356A2 (en) * 2004-12-22 2007-06-07 Ranbaxy Laboratories Limited Derivatives of pentose monosaccharides as anti-inflammatory compounds
WO2007010499A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
KR101329112B1 (ko) 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
EP1842855A3 (en) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
CN105367612A (zh) * 2014-08-13 2016-03-02 中国药科大学 龙脷叶由来天然产物丁基2-脱氧-3，6-脱水-β-D-阿拉伯糖呋喃糖苷的全合成方法
US20220356150A1 (en) * 2021-04-30 2022-11-10 Evoco Limited Biobased diisocyanates, and process for preparation of same
WO2024135721A1 (ja) * 2022-12-21 2024-06-27 田辺三菱製薬株式会社 製造中間体の製造方法、その製造中間体及びそれらを用いた架橋型人工核酸中間体の製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
DE2936240A1 (de) * 1979-09-07 1981-03-26 Bayer Ag, 51373 Leverkusen Verfahren zur herstellung bekannter und neuer 6-amino-6-desoxy-2,3-0-isopropyliden-(alpha)-l-sorbofuranose-derivate sowie neue zwischenprodukte des verfahrens
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5298494A (en) 1989-01-09 1994-03-29 Greenwich Pharmaceuticals Incorporated Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
IL100833A0 (en) 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides
US5360792A (en) 1991-12-20 1994-11-01 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom
US5360794A (en) 1992-08-03 1994-11-01 Medicarb Inc. Disubstituted and deoxy disubstituted derivatives of α-D-mannofuranosides and β-L-gulofuranosides having anti-inflammatory and anti-proliferative activity
US5367062A (en) 1992-08-21 1994-11-22 Medicarb Inc. Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity
US5508387A (en) * 1993-08-04 1996-04-16 Glycomed Incorporated Selectin binding glycopeptides
WO1995010296A1 (en) * 1993-10-12 1995-04-20 Glycomed Incorporated A library of glyco-peptides useful for identification of cell adhesion inhibitors
US5637570A (en) 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
WO1997015585A1 (fr) * 1995-10-26 1997-05-01 Kanebo, Ltd. Derives de la fucose, medicaments dont ils forment le principe actif, et leurs intermediaires de fabrication
US5824657A (en) 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders

Also Published As

Publication number Publication date
ES2223447T3 (es) 2005-03-01
DE60011568T2 (de) 2005-08-18
YU50101A (sh) 2005-07-19
EP1144425B1 (en) 2004-06-16
HK1041006A1 (en) 2002-06-28
IL144274A0 (en) 2002-05-23
CO5170511A1 (es) 2002-06-27
EP1144425A1 (en) 2001-10-17
PA8489601A1 (es) 2000-09-29
NZ512851A (en) 2004-02-27
US6329344B1 (en) 2001-12-11
HK1041006B (zh) 2005-02-04
TR200102031T2 (tr) 2001-12-21
HUP0200097A3 (en) 2003-03-28
CA2359980A1 (en) 2000-07-20
MA25679A1 (fr) 2003-04-01
AU1886000A (en) 2000-08-01
ATE269349T1 (de) 2004-07-15
CN1254478C (zh) 2006-05-03
ID30259A (id) 2001-11-15
HRP20010527A2 (en) 2002-08-31
JP2002534529A (ja) 2002-10-15
IL144274A (en) 2007-05-15
NZ527482A (en) 2005-02-25
HUP0200097A2 (hu) 2002-05-29
MY122723A (en) 2006-04-29
WO2000042053A1 (en) 2000-07-20
DE60011568D1 (de) 2004-07-22
CZ20012541A3 (cs) 2002-02-13
DK1144425T3 (da) 2004-10-18
HRP20010527B1 (en) 2005-06-30
CN1343212A (zh) 2002-04-03
SK9962001A3 (en) 2002-02-05
PT1144425E (pt) 2004-10-29
SK284568B6 (sk) 2005-06-02
AU767948B2 (en) 2003-11-27
AR033939A1 (es) 2004-01-21
BR0007489A (pt) 2002-01-02

Similar Documents

Publication Publication Date Title
BG105795A (en) Derivatives of monosaccharides as cell adhesion inhibitors
AU3912493A (en) A pharmaceutical composition containing a defined lipid system
DE69831868D1 (en) Antithrombosemittel
GR3037073T3 (en) Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof
IL133623A0 (en) Antithrombotic agents
BG104138A (en) 2-aminopyridines containing substituents with condensed rings as nos inhibitors
WO2002014311A3 (en) Urea compounds and methods of uses
AU1617901A (en) Urea derivatives as anti-inflammatory agents
WO2002010137A3 (en) Indazole derivatives as JNK inhibitors
AU2054700A (en) Antithrombotic amides
CA2388639A1 (en) Inhibitors of .alpha.l.beta.2 mediated cell adhesion
EE200100355A (et) Rakkude adhesiooni inhibeerivad põletikuvastased ja immunosupressiivsed ühendid
IL158899A0 (en) Pharmaceutical compositions for inhibiting angiogenesis containing oleuropein and derivatives thereof
HK1105977A1 (en) Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
CA2340224A1 (en) Nimesulide containing topical pharmaceutical compositions
HK1068332A1 (en) Pyrane derivatives as both ace-and nep-inhibitors
WO2004028455A3 (en) Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
AU2001282871A1 (en) Antithrombotic agents
EE9800233A (et) Benso[c]kinolisiini derivaadid, nende valmistamine ja kasutamine 5a-reduktaasi inhibiitoritena
HUP0105116A3 (en) 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors, pharmaceutical compositions containing them, process for preparation of the compounds
JO2175B1 (en) Monosaccharide derivatives are used as inhibitors to attach to cells
HK1105978A1 (en) Pyrrolo [3,2-c]pyridine derivatives and processes for the preparation thereof
AU7470098A (en) Antithrombotic agents
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
AU1434201A (en) Antithrombotic agents